ACOR Stock Summary

• In terms of twelve month growth in earnings before interest and taxes, Acorda Therapeutics Inc is reporting a growth rate of 190.04%; that's higher than 93.61% of US stocks.
• Revenue growth over the past 12 months for Acorda Therapeutics Inc comes in at -64.27%, a number that bests just 2.34% of the US stocks we're tracking.
• In terms of volatility of its share price, ACOR is more volatile than 97.98% of stocks we're observing.
• Stocks that are quantitatively similar to ACOR, based on their financial statements, market capitalization, and price volatility, are BLIN, TRXC, KODK, NLST, and LPTH.
• ACOR's SEC filings can be seen here. And to visit Acorda Therapeutics Inc's official web site, go to www.acorda.com.